Galmed Pharmaceuticals
GLMD
#9510
Rank
NZ$8.74 M
Marketcap
$13.58
Share price
21.74%
Change (1 day)
7.48%
Change (1 year)

EPS for Galmed Pharmaceuticals (GLMD)

EPS in 2023 (TTM): -$11.24

According to Galmed Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$10.81. In 2022 the company made an earnings per share (EPS) of -$17.09 an increase over its 2021 EPS that were of -$32.00.

EPS history for Galmed Pharmaceuticals from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$11.24-34.21%
2022-$17.09-46.62%
2021-$32.00-2.22%
2020-$32.7339.18%
2019-$23.5270.18%
2018-$13.82-41.84%
2017-$23.76-34.23%
2016-$36.1356.84%
2015-$23.039.2%
2014-$21.09-53.43%
2013-$45.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.09-80.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.50-39.91%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-$1.21-88.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.81-64.72%๐Ÿ‡บ๐Ÿ‡ธ USA